Emerging therapies in castration resistant prostate cancer.

Thoreson GR, Gayed BA, Chung PH, Raj GV. Emerging therapies in castration resistant prostate cancer. Can J Urol. 2014 Apr; 21(2 Supp 1):98-105.

View in: PubMed

subject areas

Androgens
Biomedical Research
Humans
Male
Prostatic Neoplasms, Castration-Resistant
Receptors, Androgen
Signal Transduction
Treatment Outcome

authors with profiles

Paul Chung

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement